Perilymph Fistula: The Diagnosis Argued Over for Fifty Years, and Fixable With Surgery

Most of what causes tinnitus cannot be repaired. This is one of the exceptions — a mechanical fault with a mechanical fix — and it is also the entry on the list that clinicians have argued about longest.

What it is

The inner ear is a sealed, fluid-filled system. The fluid is perilymph. On the other side of two membranes — the oval window and the round window — is the air-filled middle ear.

A perilymph fistula is an abnormal communication between those two spaces, or between the inner ear and the mastoid or the cranial cavity. A 2020 review in Frontiers in Neurology describes it as most commonly forming when the integrity of the oval or round window is compromised.

The consequence is not subtle in principle. A sealed hydraulic system develops a leak, and the pressure relationships the inner ear depends on stop holding. What follows is some combination of hearing loss, dizziness and tinnitus, often fluctuating and often worse with exertion, straining or pressure change.

Where it comes from

The 2018 review in Advances in Oto-Rhino-Laryngology gives both the sites and the causes.

Where the leak sits: the round or oval window, a fractured bony labyrinth, microfissures, or an anomalous footplate.

What produces it:

• Head trauma. Tinnitus after head injury covers the wider picture; this is one specific mechanism within it.
• Barotrauma — pressure change. This is the one worth flagging to divers and frequent flyers, and diving, flying and barotrauma is the article that deals with it directly.
• Chronic inflammation.
• Otic capsule dehiscence — a gap in the bony shell of the inner ear, which is the same family of problem as superior canal dehiscence. Both create an abnormal opening into a system designed to have exactly two.

And then the category that causes all the trouble. The 2020 review states it plainly: a perilymph fistula may be trauma-induced, or it may occur with no known cause — idiopathic.

The fifty-year argument

Here is the sentence that makes this subject unusual, from the 2018 review, about its own topic:

The difficulty of making a definitive diagnosis of PLF has caused a long-standing debate regarding its prevalence, natural history, management and even its very existence.

Not "its frequency is uncertain". Its existence.

The review notes the condition was first proposed more than a century ago and has remained controversial for more than 50 years. The 2020 review says the same in its own words: controversy over the diagnosis of idiopathic perilymph fistula has persisted for decades, and the presenting symptoms may be vague.

It is worth understanding why, because the reason is structural rather than anyone being unreasonable. A traumatic fistula has a cause you can point at. An idiopathic one is inferred from symptoms — dizziness, fluctuating hearing, tinnitus, pressure sensitivity — that are shared by Ménière's disease, endolymphatic hydrops, superior canal dehiscence and vestibular migraine. Confirming it historically meant exploratory surgery, and finding a leak during an operation is not a straightforward observation either.

So the field had a proposed condition, a set of non-specific symptoms, and no test. That is a recipe for a fifty-year argument, and the argument is the honest context for anything you read about this diagnosis — including confident claims in either direction.

What changed: a biomarker

The 2018 review's substantive contribution is that this is no longer purely an argument from symptoms.

It reports a nationwide survey in Japan using Cochlin-tomoprotein (CTP) — described as a novel and widely used biomarker for perilymph fistula diagnosis — and presents the results of new diagnostic criteria built on it.

The logic is worth appreciating. CTP is a protein found in perilymph. If you sample the middle ear and find perilymph proteins in a space that should contain only air, you have detected the leak itself rather than inferred it from a symptom pattern. That is a categorically different kind of evidence, and it is why the review can present criteria at all.

The same review also sets out a classification of perilymph fistula into four categories, explicitly in response to earlier criticism of the field.

Two honest caveats. A biomarker described as widely used in Japan is not necessarily available where you live, and neither review claims the controversy is closed. What they establish is that the question moved from "does this exist" to "here is how it is defined and detected", which is progress rather than resolution.

Why it is worth knowing about anyway

Because of what happens when it is found. The 2018 review:

PLF is surgically correctable by sealing the fistula, and appropriate recognition and treatment of PLF can improve hearing and balance.

And the 2020 review frames the stakes in a way that belongs on this site specifically: the potential exists for this condition to be one of the few etiologies of dizziness, tinnitus, and hearing loss that can be treated surgically.

Almost everything else in this territory is managed. Can tinnitus be cured exists because the honest answer for the ordinary kind is no. The short list of exceptions — a dural arteriovenous fistula, a sigmoid sinus wall abnormality, a glomus tumour, and this — are all cases where something physical is generating or permitting the symptom and can be closed, removed or rebuilt.

That is the argument for it being on a differential rather than dismissed, even given the controversy.

What to do with this

• If your symptoms started after a specific pressure event — a dive, a flight with a cold, a blow to the head, heavy straining — say so, with the date. A traumatic fistula is the version nobody argues about, and the sequence is the strongest evidence you have.
• If your hearing or dizziness gets worse with straining, coughing or lifting, mention that specifically. Pressure sensitivity is what points at a leak rather than at the conditions it mimics.
• If you have been told it is controversial, that is accurate rather than dismissive — and the same reviews that say so also say it is surgically correctable and that a biomarker now exists.
• If you are being offered exploratory surgery on a symptom picture alone, ask what else has been excluded and whether any objective test is available to you. Both reviews are explicit that the symptoms overlap several other conditions.
• If none of this fits — no trauma, no pressure sensitivity, no fluctuation — this is unlikely to be your answer, and the wider list of causes is the better place to start.